Supplier News

Sandoz Industrial Products GmbH will be renamed Corden BioChem and will be associated with the CordenPharma Group, ICIG’s pharmaceutical platform.

The companies will merge to create a gene therapy biologics CDMO.

The service center will act as a hub for delivery, maintenance, calibration, and technical support for the company.

The companies will provide assays for functional comparability, for use in quality control, lot release, and stability testing of biosimilars and biobetters.

A $1.1-million NSF grant awarded to Advanced Polymer Monitoring Technologies will be used for the development of a characterization technology for monitoring aggregation in biopharmaceuticals.

Collaboration will provide for unified development and manufacture of antibody drug conjugates.

The company broke ground on a $79 million production facility at its Ravensburg Schuetzenstrasse site.

The partnership aims to facilitate the development of therapeutic and diagnostic candidates for European biopharmaceutical clients.

The ready-to-use assays are specifically designed for companies looking to characterize their biosimilar products in the pipeline.

ANGUS reveals ANGUS Life Sciences as a new company division that will serve pharmaceutical, biotechnology, and agriculture markets.

With a new name formed from the legacy company names, Alcami offers development services, analytical testing, and API and finished drug development and manufacturing.

The module was installed in the company’s Watson laboratory information management system in Poitiers, France.

The investment includes facility upgrades and expansion of development capabilities.

The inspection confirmed that the facility was compliant with GMP guidelines.

Repligen reported a revenue increase of 45% at constant currency in the fourth quarter of 2015, which was driven primarily by strong growth in sales of its bioprocessing products, Jon K. Snodgrass, CFO of Repligen, noted during a fourth-quarter conference call. Specifically, the increased revenue came from the sales of its growth factors, ATF (alternating tangential flow) systems and consumables, and products from its chromatography group (e.g., OPUS columns, Protein A resins, and ELISA kits).

The advanced capillary electrophoresis system, Maurice, from ProteinSimple is used for the quantitative analysis of identity, purity, and heterogeneity profiles of biopharmaceuticals.

Curida entered into a partnership with René Bommer, PhD, founder and owner of pharmAccel Consulting.

AAIPharma/Cambridge Major Labs plans to invest $10.7 million to relocate the company’s analytical testing facility to the Cortex Innovation Center in Missouri.

Recipharm plans to invest €40 million in the project as a result of EMA decision to make serialization of licensed drug products a legal requirement by 2019.

Unchained Labs acquires Freeslate, marking the company’s fourth acquisition in the past 12 months.

The collaboration will allow the companies to develop and manufacture novel inhaled therapeutics.

This marks Vetter’s fourth internationally recognized award for its syringe closure system, Vetter-Ject.

Sartorius announced the release of the company’s new Tacta pipettes.

GRAM completed a fourth FDA inspection of its parenteral manufacturing facility with no Form 483 observation issues.

Metrohm USA awards the 2016 Young Chemist Award to PhD candidate developing wearable sensors that can non-invasively monitor physiologically relevant chemicals.

LabConnect built a biorepository facility in Tennessee.

Novasep is building a new synthesis laboratory and adding capacity for kilogram-scale batches of synthetic molecules that are needed for biological testing and preclinical trials, at its Pennsylvania, US facility.

The partnership will focus on the identification and analysis of host-cell proteins in biologics.